Medicare Group Q.P.S.C. (QSE:MCGS)
Qatar · Delayed Price · Currency is QAR 5.25
-0.09 (-1.59%)
Nov 12, 2026, 1:09 PM AST
Medicare Group Q.P.S.C. Income Statement
Financials in millions QAR. Fiscal year is January - December.
Millions QAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 478.93 | 502.6 | 523.49 | 485.96 | 487.17 | 483.63 | |
Revenue Growth | -7.39% | -3.99% | 7.72% | -0.25% | 0.73% | 1.43% |
Cost of Revenue | 339.47 | 334.36 | 334.39 | 319.65 | 309.82 | 306.1 |
Gross Profit | 139.47 | 168.24 | 189.1 | 166.3 | 177.34 | 177.52 |
Selling, General & Admin | 98.76 | 90.08 | 91.21 | 84.48 | 84.6 | 82.31 |
Operating Expenses | 39.84 | 105.5 | 106.48 | 98.51 | 103.64 | 101.4 |
Operating Income | 99.63 | 62.74 | 82.62 | 67.79 | 73.7 | 76.12 |
Interest Expense | -0.14 | - | - | -0.02 | -2.06 | -3.14 |
Interest & Investment Income | 4.46 | 6.57 | 7.78 | 3.22 | 2.89 | 2.27 |
Currency Exchange Gain (Loss) | - | - | - | - | - | 0.01 |
Other Non Operating Income (Expenses) | 21.23 | 6.7 | 3.78 | 5.21 | 4.28 | 3.79 |
EBT Excluding Unusual Items | 125.19 | 76.01 | 94.18 | 76.19 | 78.81 | 79.05 |
Asset Writedown | -0 | -0 | -0.03 | 0.04 | 0.35 | 0.01 |
Pretax Income | 125.19 | 76.01 | 94.15 | 76.23 | 79.16 | 79.06 |
Earnings From Continuing Operations | 125.19 | 76.01 | 94.15 | 76.23 | 79.16 | 79.06 |
Earnings From Discontinued Operations | - | - | -34.1 | -10.53 | - | - |
Net Income | 125.19 | 76.01 | 60.06 | 65.7 | 79.16 | 79.06 |
Net Income to Common | 125.19 | 76.01 | 60.06 | 65.7 | 79.16 | 79.06 |
Net Income Growth | 45.40% | 26.57% | -8.59% | -17.01% | 0.13% | -7.54% |
Shares Outstanding (Basic) | 281 | 281 | 281 | 281 | 281 | 281 |
Shares Outstanding (Diluted) | 281 | 281 | 281 | 281 | 281 | 281 |
Shares Change | 0.01% | - | - | - | - | - |
EPS (Basic) | 0.44 | 0.27 | 0.21 | 0.23 | 0.28 | 0.28 |
EPS (Diluted) | 0.44 | 0.27 | 0.21 | 0.23 | 0.28 | 0.28 |
EPS Growth | 45.38% | 26.57% | -8.59% | -17.01% | 0.13% | -7.54% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 129.18 | 35.15 | 54.2 | 24.01 | 57.68 | 39.54 |
Free Cash Flow Per Share | 0.46 | 0.13 | 0.19 | 0.09 | 0.20 | 0.14 |
Dividend Per Share | 0.220 | 0.220 | 0.198 | 0.220 | 0.263 | 0.250 |
Dividend Growth | 11.11% | 11.11% | -10.00% | -16.19% | 5.00% | -10.71% |
Gross Margin | 29.12% | 33.47% | 36.12% | 34.22% | 36.40% | 36.71% |
Operating Margin | 20.80% | 12.48% | 15.78% | 13.95% | 15.13% | 15.74% |
Profit Margin | 26.14% | 15.12% | 11.47% | 13.52% | 16.25% | 16.35% |
Free Cash Flow Margin | 26.97% | 6.99% | 10.35% | 4.94% | 11.84% | 8.18% |
EBITDA | 127.96 | 89.14 | 107.24 | 90.2 | 99.53 | 100.72 |
EBITDA Margin | 26.72% | 17.73% | 20.48% | 18.56% | 20.43% | 20.83% |
D&A For EBITDA | 28.33 | 26.4 | 24.62 | 22.41 | 25.83 | 24.6 |
EBIT | 99.63 | 62.74 | 82.62 | 67.79 | 73.7 | 76.12 |
EBIT Margin | 20.80% | 12.48% | 15.78% | 13.95% | 15.13% | 15.74% |
Advertising Expenses | - | 2.25 | 2.65 | 1.49 | 1.13 | 1.2 |